{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:32:32Z","timestamp":1749051152725,"version":"3.40.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"DOI":"10.7759\/cureus.82793","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:11:08Z","timestamp":1745338268000},"source":"Crossref","is-referenced-by-count":13,"title":["When Software Becomes Medicine: Ignoring It May Soon Be Malpractice"],"prefix":"10.7759","author":[{"given":"Shaheen E","family":"Lakhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Digital Health Technologies for Opioid Use Disorder. Final Evidence Report. (2022). Accessed: April 13, 2025: https:\/\/icer.org\/wp-content\/uploads\/2020\/08\/ICER_DHTs_for_OUD_Final_Report_052722.pdf."},{"key":"ref2","unstructured":"Rejoyn Clinician Brief Summary. (2024). Accessed. April 13, 2025: https:\/\/www.rejoynhcp.com\/Clinician-Brief-Summary.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210426","article-title":"Efficacy and safety of a first-in-class investigational prescription digital therapeutic for episodic migraine (CT-132): phase 3 double-blind, randomized, controlled trial (P4-12.006)","volume":"104","author":"Snipes C","year":"2025","unstructured":"Snipes C, Kuka A, Petrova M, et al.. Efficacy and safety of a first-in-class investigational prescription digital therapeutic for episodic migraine (CT-132): phase 3 double-blind, randomized, controlled trial (P4-12.006). Neurology. 2025, 104:10.1212\/WNL.0000000000210426","journal-title":"Neurology"},{"key":"ref4","unstructured":"De Novo Classification Request for Luminopia One. (2021). Accessed. April 21, 2025: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN210005.pdf."},{"key":"ref5","unstructured":"A Study of CT-155 in Subjects With Schizophrenia (CONVOKE). NCT05838625. (2025). Accessed. April 13, 2025: https:\/\/clinicaltrials.gov\/study\/NCT05838625."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362521-when-software-becomes-medicine-ignoring-it-may-soon-be-malpractice","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:11:10Z","timestamp":1745338270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362521-when-software-becomes-medicine-ignoring-it-may-soon-be-malpractice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.82793","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}